US$ 26.75
glutathione healing crisis Tumor-targeted oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Nineteen-year follow-up of a patient
Description
In this reaction, there is the formation of a peptide bond between an amino acid and drug molecules

Hostynek JJ, Dreher F, Maibach HI

It has been demonstrated that over 50% of human cancers is characterized by the occurrence of loss of function mutations in the TP53 gene [123]

MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway
